CSRXP: COVID-19 TREATMENTS AND VACCINES MUST BE ACCESSIBLE AND AFFORDABLE FOR ALL AMERICANS

11-9-2020 Press Release

Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to Affordable Pricing Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Monday reacting to preliminary data released by Pfizer Inc. on the efficacy of the company’s COVID-19 vaccine. “Any COVID-19 treatments and vaccines that ultimately come to market must be priced […]

CSRXP: PRESIDENTIAL CAMPAIGNS MUST BACK BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

10-13-2020 Press Release

Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering Rx Prices and Reject Big Pharma Blame Game in Town Hall Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday ahead of a drug pricing town hall with representatives from both the Trump and Biden campaigns hosted by Patients for […]

CSRXP: ASTRAZENECA LEADS BIG PHARMA IN BRAZEN ASSAULT ON CRITICAL 340B PROGRAM, MUST BE HELD ACCOUNTABLE

10-1-2020 Press Release

Brand Name Drug Company Shirks Requirement to Provide Affordable Medications to Covered Providers as Industry Complains About High Discounts Partially Driven by Its Own Price Hikes Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday criticizing AstraZeneca for becoming the second Big Pharma giant to brazenly stop recognizing legally mandated prescription drug discounts […]

CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES

09-30-2020 Press Release

House Committee on Oversight and Reform to Question Big Pharma Executives During Two-Day Hearing on “Unsustainable Drug Prices” Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday ahead of two days of testimony from Big Pharma executives before the U.S. House Committee on Oversight and Reform on “Unsustainable Drug Prices.” […]

NEW STUDY: BIG PHARMA’S BIOLOGIC PATENT ABUSE WILL COST AMERICAN PATIENTS AN ADDITIONAL $25 BILLION WITHOUT REFORM

09-22-2020 Press Release

Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold Drug Companies Accountable Would Lower Prices And Increase Innovation Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a new study from Avik Roy and Gregg Girvan of the Foundation for Research on Equal Opportunity (FREOPP) which finds […]

CSRXP: PRESIDENT SHOULD FOCUS ON HOLDING BIG PHARMA ACCOUNTABLE TO LOWER RX PRICES, ABANDON REBATE RULE

09-13-2020 Press Release

Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Drug Prices, While Increasing Medicare Premiums Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Sunday in response to tweet chain from the president announcing he signed an executive order tying drug prices to those paid in other countries and pointing […]

CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices

09-1-2020 Press Release

U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of Blockbuster Cancer, Immunosuppressant Drugs Will Help Hold Industry Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to news that the U.S. House Oversight Committee will subpoena Big Pharma giant AbbVie to obtain documents related to […]

BIG PHARMA DOUBLES DOWN ON SUMMER PRICE HIKES AS AMERICANS CONTINUE TO BATTLE PANDEMIC

08-27-2020 Press Release

Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name Drugs This Summer Despite Economic Crisis and Rising Concern With Rx Affordability Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on updated data showing Big Pharma continued hiking prescription drug prices through the summer while Americans […]

CSRXP: BIG PHARMA’S COUNTEROFFER TO WHITE HOUSE WOULD HURT AMERICAN SENIORS & DO NOTHING TO LOWER DRUG PRICES

08-26-2020 Press Release

White House Should Reject Pharma-Backed Policies That Would Hand Drug Companies a Windfall on the Backs of American Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday in response to two alternative drug pricing proposals to Medicare Parts B and D presented by Big Pharma to the Trump administration […]

CSRXP LAUNCHES TELEVISION AND DIGITAL AD CAMPAIGN AGAINST REBATE RULE, AKA BIG PHARMA BAILOUT

08-4-2020 Press Release

Encourages Administration to Reject Measure That Would Increase Premiums on Medicare Part D Beneficiaries, Cost Taxpayers Billions and Boost Profits for Drug Companies Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched a television and digital advertising campaign Tuesday against the proposed Rebate Rule in Washington, D.C. and eight key U.S. Senate and […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.